The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients

Keyphrases

• Clinical Utility 100%
• Breast Cancer Patients 100%
• Circulating Tumor DNA (ctDNA) 100%
• Droplet Digital PCR (ddPCR) 100%
• Breast Cancer 50%
• Mutated Genes 25%
• High Sensitivity 25%
• High Capacity 25%
• Cancer Patients 25%
• Common Cancers 25%
• Cell-free 25%
• Malignant Disease 25%
• Molecular Subtypes 25%
• Heterogeneous Disease 25%
• Recurrence Risk 25%
• Systemic Therapy 25%
• Targeted Therapy 25%
• Tumor Protein p53 (TP53) 25%
• Human Epidermal Growth Factor Receptor 2 (HER2) 25%
• Minimally Invasive Diagnostics 25%
• Blood Plasma 25%
• Patient Identification 25%
• Liquid Biopsy 25%
• Mutational Profiling 25%
• PIK3CA 25%
• Tumor DNA 25%
• Absolute Quantification 25%
• Estrogen Receptor 1 (ESR1) 25%
• Efficacy Assessment 25%
• Cancer mutations 25%
• Serial Monitoring 25%
• Invasive Diagnostic Procedures 25%
• Risk of Progression 25%

Medicine and Dentistry

• Breast Cancer 100%
• Circulating Tumor DNA 100%
• Droplet Digital Polymerase Chain Reaction 100%
• Malignant Neoplasm 75%
• Neoplasm 25%
• Reproducibility 25%
• Disease 25%
• Recurrent Disease 25%
• Diagnostic Test 25%
• Targeted Therapy 25%
• Invasive Diagnostics 25%
• Liquid Biopsy 25%
• Blood Plasma 25%
• Efficacy Assessment 25%